1
|
Reyes SJ, Lemire L, Molina RS, Roy M, L'Ecuyer-Coelho H, Martynova Y, Cass B, Voyer R, Durocher Y, Henry O, Pham PL. Multivariate data analysis of process parameters affecting the growth and productivity of stable Chinese hamster ovary cell pools expressing SARS-CoV-2 spike protein as vaccine antigen in early process development. Biotechnol Prog 2024:e3467. [PMID: 38660973 DOI: 10.1002/btpr.3467] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2024] [Revised: 03/25/2024] [Accepted: 03/28/2024] [Indexed: 04/26/2024]
Abstract
The recent COVID-19 pandemic revealed an urgent need to develop robust cell culture platforms which can react rapidly to respond to this kind of global health issue. Chinese hamster ovary (CHO) stable pools can be a vital alternative to quickly provide gram amounts of recombinant proteins required for early-phase clinical assays. In this study, we analyze early process development data of recombinant trimeric spike protein Cumate-inducible manufacturing platform utilizing CHO stable pool as a preferred production host across three different stirred-tank bioreactor scales (0.75, 1, and 10 L). The impact of cell passage number as an indicator of cell age, methionine sulfoximine (MSX) concentration as a selection pressure, and cell seeding density was investigated using stable pools expressing three variants of concern. Multivariate data analysis with principal component analysis and batch-wise unfolding technique was applied to evaluate the effect of critical process parameters on production variability and a random forest (RF) model was developed to forecast protein production. In order to further improve process understanding, the RF model was analyzed with Shapley value dependency plots so as to determine what ranges of variables were most associated with increased protein production. Increasing longevity, controlling lactate build-up, and altering pH deadband are considered promising approaches to improve overall culture outcomes. The results also demonstrated that these pools are in general stable expressing similar level of spike proteins up to cell passage 11 (~31 cell generations). This enables to expand enough cells required to seed large volume of 200-2000 L bioreactor.
Collapse
Affiliation(s)
- Sebastian-Juan Reyes
- Department of Chemical Engineering, Polytechnique Montreal, Montreal, Canada
- Human Health Therapeutics Research Centre, National Research Council Canada, Canada
| | - Lucas Lemire
- Department of Chemical Engineering, Polytechnique Montreal, Montreal, Canada
- Human Health Therapeutics Research Centre, National Research Council Canada, Canada
| | | | - Marjolaine Roy
- Human Health Therapeutics Research Centre, National Research Council Canada, Canada
| | | | - Yuliya Martynova
- Human Health Therapeutics Research Centre, National Research Council Canada, Canada
| | - Brian Cass
- Human Health Therapeutics Research Centre, National Research Council Canada, Canada
| | - Robert Voyer
- Human Health Therapeutics Research Centre, National Research Council Canada, Canada
| | - Yves Durocher
- Human Health Therapeutics Research Centre, National Research Council Canada, Canada
| | - Olivier Henry
- Department of Chemical Engineering, Polytechnique Montreal, Montreal, Canada
| | - Phuong Lan Pham
- Human Health Therapeutics Research Centre, National Research Council Canada, Canada
| |
Collapse
|
2
|
Fang S, Sinanan DJ, Perez MH, Cruz-Quintero RG, Jadhav SR. Development of a high-throughput scale-down model in Ambr® 250 HT for plasmid DNA fermentation processes. Biotechnol Prog 2024:e3458. [PMID: 38494959 DOI: 10.1002/btpr.3458] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2024] [Revised: 02/28/2024] [Accepted: 03/06/2024] [Indexed: 03/19/2024]
Abstract
Recent advances in messenger ribonucleic acid (mRNA) vaccines and gene therapy vectors have increased the need for rapid plasmid DNA (pDNA) screening and production within the biopharmaceutical industry. High-throughput (HT) fermentor systems, such as the Ambr® 250 HT, can significantly accelerate process development timelines of pDNA upstream processes compared to traditional bench-scale glass fermentors or small-scale steam-in-place (SIP) fermentors. However, such scale-down models must be qualified to ensure that they are representative of the larger scale process similar to traditional small-scale models. In the current study, we developed a representative scale-down model of a Biostat® D-DCU 30 L pDNA fermentation process in Ambr® 250 HT fermentors using three cell lines producing three different constructs. The Ambr scale-down model provided comparable process performance and pDNA quality as the 30 L SIP fermentation process. In addition, we demonstrated the predictive value of the Ambr model by two-way qualification, first by accurately reproducing the prior trends observed in a 30 L process, followed by predicting new process trends that were then successfully reproduced in the 30 L process. The representative and predictive scale-down Ambr model developed in this study would enable a faster and more efficient approach to strain/clone/host-cell screening, pDNA process development and characterization studies, process scale-up studies, and manufacturing support.
Collapse
Affiliation(s)
- Shu Fang
- BioProcess Research & Development, Pfizer Inc., Chesterfield, Missouri, USA
| | - Dillon J Sinanan
- BioProcess Research & Development, Pfizer Inc., Chesterfield, Missouri, USA
| | - Marc H Perez
- BioProcess Research & Development, Pfizer Inc., Chesterfield, Missouri, USA
| | | | - Sachin R Jadhav
- BioProcess Research & Development, Pfizer Inc., Chesterfield, Missouri, USA
| |
Collapse
|
3
|
Fratz-Berilla EJ, Kohnhorst C, Trunfio N, Bush X, Gyorgypal A, Agarabi C. Evaluation of single-use optical and electrochemical pH sensors in upstream bioprocessing. Heliyon 2024; 10:e25512. [PMID: 38371965 PMCID: PMC10873650 DOI: 10.1016/j.heliyon.2024.e25512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2024] [Revised: 01/22/2024] [Accepted: 01/29/2024] [Indexed: 02/20/2024] Open
Abstract
Culture pH is a critical process parameter during CHO cell bioreactor operations that is key for proper cell growth, protein production, and maintaining the critical quality attributes of a monoclonal antibody drug substance. The traditional means of measuring pH in bioreactors is with an electrochemical probe that can withstand and maintain accuracy through repeated sterilization cycles. An alternative technique for measuring pH is an optical sensor composed of a fluorescent dye that is sensitive to the hydrogen ion concentration. In this work we explore single-use electrochemical and single-use optical pH sensors in stirred-tank and rocking bioreactors, respectively, to understand how their overall performance compares to traditional electrochemical probes in benchtop glass stirred tank bioreactors. We found that the single-use optical pH sensors were generally less accurate than the electrochemical probes, especially in detecting large pH drifts from the setpoint. The single-use electrochemical probes were increasingly accurate as pH was increased from <7.0 to 7.5 but tended to decrease in accuracy as the batch age increased. In conclusion, single-use pH sensors offer a convenient means to measure pH during an upstream bioprocess, but the limitations of these sensors should be built into process control such that deviations in process pH, and consequently potential fluctuations in product quality, can be avoided.
Collapse
Affiliation(s)
- Erica J. Fratz-Berilla
- U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, Silver Spring, MD, USA
| | - Casey Kohnhorst
- U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, Silver Spring, MD, USA
| | - Nicholas Trunfio
- U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, Silver Spring, MD, USA
| | - Xin Bush
- U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, Silver Spring, MD, USA
- Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, USA
| | - Aron Gyorgypal
- Department of Chemical and Biochemical Engineering, School of Engineering, Rutgers the State University of New Jersey, Piscataway, NJ, 08854, USA
| | - Cyrus Agarabi
- U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, Silver Spring, MD, USA
| |
Collapse
|
4
|
Zhao L, Wang C, Wang J, Fan L, Chen M, Ye Q, Tan WS. Low CO 2 partial pressure steers CHO cells into a defective metabolic state. Biotechnol Lett 2023; 45:1103-1115. [PMID: 37318718 DOI: 10.1007/s10529-023-03404-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2022] [Revised: 05/17/2023] [Accepted: 05/24/2023] [Indexed: 06/16/2023]
Abstract
PURPOSE The accumulation of carbon dioxide during large-scale culture of animal cells brings adverse effects, appropriate aeration strategies alleviate CO2 accumulation while improper reactor operation may lead to the presence of low CO2 partial pressure (pCO2) condition as occurs in many industrial cases. Thus, this study aims to reveal the in-depth influence of low pCO2 on Chinese Hamster Ovary (CHO) cells for providing a reference for design space determination of CO2 control with regard to the Quality by Design (QbD) guidelines. METHODS AND RESULTS The headspace air over purging caused the ultra-low pCO2 (ULC) where the monoclonal antibody production as well as the aerobic metabolic activity were reduced. Intracellular metabolomics analysis indicated a less efficient aerobic glucose metabolic state under ULC conditions. Based on the increase of intracellular pH and lactate dehydrogenase activity, the shortage of intracellular pyruvate could be the cause of the deficient aerobic metabolism, which could be partially mitigated by pyruvate addition under ULC conditions. Finally, a semi-empirical mathematical model was used to better understand, predict and control the occurrence of extreme pCO2 conditions during the cultures of CHO cells. CONCLUSION Low pCO2 steers CHO cells into a defective metabolic state. A predictive relation among pCO2, lactate, and pH control was applied to get new insights into CHO cell culture for better and more robust metabolic behavior and process performance and the determination of QbD design space for CO2 control.
Collapse
Affiliation(s)
- Liang Zhao
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Meilong Road, P. O. Box 309#, Shanghai, 200237, People's Republic of China
| | - Chen Wang
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Meilong Road, P. O. Box 309#, Shanghai, 200237, People's Republic of China
| | - Jiaqi Wang
- Shanghai BioEngine Sci-Tech Co., LTD, Shanghai, 201203, People's Republic of China
| | - Li Fan
- Shanghai BioEngine Sci-Tech Co., LTD, Shanghai, 201203, People's Republic of China
| | - Min Chen
- Shanghai BioEngine Sci-Tech Co., LTD, Shanghai, 201203, People's Republic of China
| | - Qian Ye
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Meilong Road, P. O. Box 309#, Shanghai, 200237, People's Republic of China.
| | - Wen-Song Tan
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Meilong Road, P. O. Box 309#, Shanghai, 200237, People's Republic of China
| |
Collapse
|
5
|
Tamminen A, Turunen R, Barth D, Vidgren V, Wiebe MG. Use of ambr ®250 to assess mucic acid production in fed-batch cultures of a marine Trichoderma sp. D-221704. AMB Express 2022; 12:90. [PMID: 35831483 PMCID: PMC9279543 DOI: 10.1186/s13568-022-01436-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2022] [Accepted: 07/06/2022] [Indexed: 11/10/2022] Open
Abstract
Mucic acid, a diacid with potential use in the food, cosmetic, chemical and pharmaceutical industries, can be produced by microbial conversion of D-galacturonic acid, which is abundant in pectin. Using the ambr®250 bioreactor system, we found that a recently generated transformant (D-221704, formerly referred to as T2) of a marine Trichoderma species produced up to 53 g L-1 mucic acid in glucose-limited fed-batch culture with D-galacturonic acid in the feed at pH 4, with a yield of 0.99 g mucic acid per g D-galacturonic acid consumed. Yeast extract was not essential for high production, but increased the initial production rate. Reducing the amount of glucose as the co-substrate reduced the amount of mucic acid produced to 31 g L-1. Mucic acid could also be produced at pH values less than 4.0 (3.5 and 3.0), but the amount produced was less than at pH 4.0. Furthermore, the yield of mucic acid on D-galacturonic acid at the end of the cultivations (0.5 to 0.7 g g-1) at these low pH levels suggested that recovery may be more difficult at lower pH on account of the high level of crystal formation. Another strain engineered to produce mucic acid, Trichoderma reesei D-161646, produced only 31 g L-1 mucic acid under the conditions used with D-221704.
Collapse
Affiliation(s)
- Anu Tamminen
- VTT Technical Research Centre of Finland Ltd, Tietotie 2, P.O. Box 1000, 02044, Espoo, Finland
| | - Rosaliina Turunen
- VTT Technical Research Centre of Finland Ltd, Tietotie 2, P.O. Box 1000, 02044, Espoo, Finland
| | - Dorothee Barth
- VTT Technical Research Centre of Finland Ltd, Tietotie 2, P.O. Box 1000, 02044, Espoo, Finland
| | - Virve Vidgren
- VTT Technical Research Centre of Finland Ltd, Tietotie 2, P.O. Box 1000, 02044, Espoo, Finland
| | - Marilyn G Wiebe
- VTT Technical Research Centre of Finland Ltd, Tietotie 2, P.O. Box 1000, 02044, Espoo, Finland.
| |
Collapse
|
6
|
Reyes SJ, Durocher Y, Pham PL, Henry O. Modern Sensor Tools and Techniques for Monitoring, Controlling, and Improving Cell Culture Processes. Processes (Basel) 2022; 10:189. [DOI: 10.3390/pr10020189] [Citation(s) in RCA: 22] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
The growing biopharmaceutical industry has reached a level of maturity that allows for the monitoring of numerous key variables for both process characterization and outcome predictions. Sensors were historically used in order to maintain an optimal environment within the reactor to optimize process performance. However, technological innovation has pushed towards on-line in situ continuous monitoring of quality attributes that could previously only be estimated off-line. These new sensing technologies when coupled with software models have shown promise for unique fingerprinting, smart process control, outcome improvement, and prediction. All this can be done without requiring invasive sampling or intervention on the system. In this paper, the state-of-the-art sensing technologies and their applications in the context of cell culture monitoring are reviewed with emphasis on the coming push towards industry 4.0 and smart manufacturing within the biopharmaceutical sector. Additionally, perspectives as to how this can be leveraged to improve both understanding and outcomes of cell culture processes are discussed.
Collapse
|
7
|
Salim T, Chauhan G, Templeton N, Ling WLW. Using MVDA with stoichiometric balances to optimize amino acid concentrations in chemically defined CHO cell culture medium for improved culture performance. Biotechnol Bioeng 2021; 119:452-469. [PMID: 34811720 DOI: 10.1002/bit.27998] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2021] [Revised: 10/22/2021] [Accepted: 11/13/2021] [Indexed: 11/07/2022]
Abstract
Chemically defined (CD) media are routinely used in the production of biologics in Chinese hamster ovary (CHO) cell culture and provide enhanced raw material control. Nutrient optimized CD media is an important path to increase cell growth and monoclonal antibody (mAb) productivity in recombinant CHO cell lines. However, nutrient optimization efforts for CD media typically rely on multifactorial and experimental design of experiment approaches or complex mathematical models of cellular metabolism or gene expression systems. Moreover, the majority of these efforts are aimed at amino acids since they constitute essential nutrients in CD media as they directly contribute to biomass and protein production. In this study, we demonstrate the utilization of multivariate data analytics (MVDA) coupled with amino acid stoichiometric balances (SBs) to increased cell growth and mAb productivity in efforts to support CD media development efforts. SBs measure the difference between theoretical demand of amino acids and the empirically measured fluxes to identify various catabolic or anabolic states of the cell. When coupled with MVDA, the statistical models were not only able to highlight key amino acids toward cell growth or productivity, but also provided direction on metabolic favorability of the amino acid. Experimental validation of our approach resulted in a 55% increase in total cell growth and about an 80% increase in total mAb productivity. Increased specific consumption of stoichiometrically balanced amino acids and decreased specific consumption of glucose was also observed in optimized CD media suggesting favorable consumption of desired nutrients and a potential for energy redistribution toward increased cellular growth and mAb productivity.
Collapse
Affiliation(s)
- Taha Salim
- Merck & Co. Inc., Kenilworth, New Jersey, USA
- Taha Salim, Regeneron, Tarrytown, New York, USA
| | | | | | - Wai Lam W Ling
- Merck & Co. Inc., Kenilworth, New Jersey, USA
- Wai L. W. Ling, Rocket Pharma, Cranbury, New Jersey, USA
| |
Collapse
|
8
|
Sharma S, Verma R, Dhull S, Maiti SK, Pandey LM. Biodegradation of waste cooking oil and simultaneous production of rhamnolipid biosurfactant by Pseudomonas aeruginosa P7815 in batch and fed-batch bioreactor. Bioprocess Biosyst Eng 2021. [PMID: 34767073 DOI: 10.1007/s00449-021-02661-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2021] [Accepted: 10/23/2021] [Indexed: 10/19/2022]
Abstract
Biosurfactants are non-toxic, surface-active biomolecules capable of reducing surface tension (ST) and emulsifying interface at a comparably lower concentration than commercial surfactants. Yet, poor yield, costlier substrates, and complex cultivation processes limit their commercial applications. This study focuses on producing biosurfactants by Pseudomonas aeruginosa P7815 in batch and fed-batch bioreactor systems using waste cooking oil (WCO) as the sole carbon source. The batch study showed a 92% of WCO biodegradation ability of P. aeruginosa producing 11 g L-1 of biosurfactant. To enhance this biosurfactant production, a fed-batch oil feeding strategy was opted to extend the stationary phase of the bacterium and minimize the effects of substrate deprivation. An enhanced biosurfactant production of 16 g L-1 (i.e. 1.5 times of batch study) was achieved at a feed rate of 5.7 g L-1d-1 with almost 94% of WCO biodegradation activity. The biosurfactant was characterized as rhamnolipid using Fourier transform infrared spectroscopy (FTIR), and its interfacial characterization showed ST reduction to 29 ± 1 mN m-1 and effective emulsification stability at pH value of 4, temperature up to 40 °C and salinity up to 40 g L-1. The biosurfactant exhibited antibacterial activity with minimum inhibitory concentration (MIC) values of 100 µg mL-1 and 150 µg mL-1 for pathogenic E. hirae and E. coli, respectively. These findings suggest that biodegradation of WCO by P. aeruginosa in a fed-batch cultivation strategy is a potential alternative for the economical production of biosurfactants, which can be further explored for biomedical, cosmetics, and oil washing/recovery applications.
Collapse
|
9
|
Schmid A, Kreidl E, Bertschinger M, Vetsch P. Benchtop Bioreactors in Mammalian Cell Culture: Overview and Guidelines. Methods Mol Biol 2021. [PMID: 34611816 DOI: 10.1007/7651_2021_441] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Bioreactors are manufactured apparatuses that allow the generation of a specific environment for the highly controlled cultivation of living cells. Originally used for microbial production systems, they have found widespread applications in fields as diverse as vaccine production, plant cell cultivation, and the growth of human brain organoids and exist in equally diverse designs (Chu and Robinson, Curr Opin Biotechnol 12(2):180-187, 2001; Qian et al., Nat Protoc 13:565-580, 2018). Manufacturing of biologics is currently mostly performed using a stirred tank bioreactor and CHO host cells and represents the most "classical" bioreactor production process. In this chapter, we will therefore use the cultivation of suspension Chinese hamster ovary (CHO) cells for recombinant protein production in a stirred tank bioreactor as an example. However, general guidelines provided in this chapter are transferable to different bioreactor types and host cells (Li et al., MAbs 2(5):466-479, 2010).The preparation and operation of a bioreactor (also referred to as upstream process in a biotechnological/industrial setting) is comprised of three main steps: expansion (generation of biomass), production (batch, fed-batch, or continuous process), and harvest. The expansion of cells can last from few days to weeks depending on the number of cells at the start, the cellular doubling time, and the required biomass to inoculate the production bioreactor. The production phase lasts a few weeks and is a highly sensitive phase as the concentration of different chemicals and physical parameters need to be tightly controlled. Finally, the harvest will allow the separation of the product of interest from large particles and then the desired material (cell culture supernatant or cells) is transferred to the downstream process.The raw materials used during the upstream phase (all three steps) need to be aligned with the final purpose of the manufactured product, as the presence of residual impurities may have an impact on suitability of the final product for a desired purpose.
Collapse
|
10
|
Ahleboot Z, Khorshidtalab M, Motahari P, Mahboudi R, Arjmand R, Mokarizadeh A, Maleknia S. Designing a Strategy for pH Control to Improve CHO Cell Productivity in Bioreactor. Avicenna J Med Biotechnol 2021; 13:123-130. [PMID: 34484641 PMCID: PMC8377406 DOI: 10.18502/ajmb.v13i3.6365] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2020] [Accepted: 12/26/2020] [Indexed: 11/24/2022] Open
Abstract
BACKGROUND Drastic pH drop is a common consequence of scaling up a mammalian cell culture process, where it may affect the final performance of cell culture. Although CO2 sparging and base addition are used as common approaches for pH control, these strategies are not necessarily successful in large scale bioreactors due to their effect on osmolality and cell viability. Accordingly, a series of experiments were conducted using an IgG1 producing Chinese Hamster Ovary (CHO-S) cell culture in 30 L bioreactor to assess the efficiency of an alternative strategy in controlling culture pH. METHODS Factors inducing partial pressure of CO2 and lactate accumulation (as the main factors altering culture pH) were assessed by Plackett-Burman design to identify the significant ones. As culture pH directly influences process productivity, protein titer was measured as the response variable. Subsequently, Central Composite Design (CCD) was employed to obtain a model for product titer prediction as a function of individual and interaction effects of significant variables. RESULTS The results indicated that the major factor affecting pH is non-efficient CO2 removal. CO2 accumulation was found to be affected by an interaction between agitation speed and overlay air flow rate. Accordingly, after increasing the agitation speed and headspace aeration, the culture pH was successfully maintained in the range of 6.95-7.1, resulting in 51% increase in final product titer. Similar results were obtained during 250 L scale bioreactor culture, indicating the scalability of the approach. CONCLUSION The obtained results showed that pH fluctuations could be effectively controlled by optimizing CO2 stripping.
Collapse
Affiliation(s)
- Zohreh Ahleboot
- Biopharmaceutical Research Center, Aryogen Pharmed Inc., Alborz University of Medical Sciences, Karaj, Iran
| | - Mahdi Khorshidtalab
- Biopharmaceutical Research Center, Aryogen Pharmed Inc., Alborz University of Medical Sciences, Karaj, Iran
| | - Paria Motahari
- Biopharmaceutical Research Center, Aryogen Pharmed Inc., Alborz University of Medical Sciences, Karaj, Iran
| | - Rasoul Mahboudi
- Biopharmaceutical Research Center, Aryogen Pharmed Inc., Alborz University of Medical Sciences, Karaj, Iran
| | - Razieh Arjmand
- Biopharmaceutical Research Center, Aryogen Pharmed Inc., Alborz University of Medical Sciences, Karaj, Iran
| | - Aram Mokarizadeh
- Biopharmaceutical Research Center, Aryogen Pharmed Inc., Alborz University of Medical Sciences, Karaj, Iran
| | - Shayan Maleknia
- Biopharmaceutical Research Center, Aryogen Pharmed Inc., Alborz University of Medical Sciences, Karaj, Iran
| |
Collapse
|
11
|
Rathore AS, Mishra S, Nikita S, Priyanka P. Bioprocess Control: Current Progress and Future Perspectives. Life (Basel) 2021; 11:life11060557. [PMID: 34199245 PMCID: PMC8231968 DOI: 10.3390/life11060557] [Citation(s) in RCA: 22] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2021] [Revised: 06/09/2021] [Accepted: 06/10/2021] [Indexed: 02/07/2023] Open
Abstract
Typical bioprocess comprises of different unit operations wherein a near optimal environment is required for cells to grow, divide, and synthesize the desired product. However, bioprocess control caters to unique challenges that arise due to non-linearity, variability, and complexity of biotech processes. This article presents a review of modern control strategies employed in bioprocessing. Conventional control strategies (open loop, closed loop) along with modern control schemes such as fuzzy logic, model predictive control, adaptive control and neural network-based control are illustrated, and their effectiveness is highlighted. Furthermore, it is elucidated that bioprocess control is more than just automation, and includes aspects such as system architecture, software applications, hardware, and interfaces, all of which are optimized and compiled as per demand. This needs to be accomplished while keeping process requirement, production cost, market value of product, regulatory constraints, and data acquisition requirements in our purview. This article aims to offer an overview of the current best practices in bioprocess control, monitoring, and automation.
Collapse
|
12
|
Bringley DA, Roberts BJ, Calimsiz S, Brown BH, Davy JA, Kwong B, Gao D, Martins A, Sarma K, Shao E, Shen J, Smith MV, Sujino K, Triman AS, Wright N. Synthesis of Rovafovir Etalafenamide (Part II): Dynamic Control for Successful Scale-Up of an Oxygen-Releasing Elimination Reaction Mediated by Oxone. Org Process Res Dev 2021. [DOI: 10.1021/acs.oprd.0c00439] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Dustin A. Bringley
- Gilead Sciences Inc., Department of Process Chemistry, 333 Lakeside Drive, Foster City, California 94404, United States
| | - Benjamin J. Roberts
- Gilead Sciences Inc., Department of Process Chemistry, 333 Lakeside Drive, Foster City, California 94404, United States
| | - Selcuk Calimsiz
- Gilead Alberta ULC, Department of Process Chemistry, 1021 Hayter Road NW, Edmonton, Alberta T6S 1A1, Canada
| | - Brandon H. Brown
- Gilead Sciences Inc., Department of Process Chemistry, 333 Lakeside Drive, Foster City, California 94404, United States
| | - Jason A. Davy
- Gilead Alberta ULC, Department of Process Chemistry, 1021 Hayter Road NW, Edmonton, Alberta T6S 1A1, Canada
| | - Bernard Kwong
- Gilead Alberta ULC, Department of Process Chemistry, 1021 Hayter Road NW, Edmonton, Alberta T6S 1A1, Canada
| | - Detian Gao
- Gilead Alberta ULC, Department of Process Chemistry, 1021 Hayter Road NW, Edmonton, Alberta T6S 1A1, Canada
| | - Andrew Martins
- Gilead Alberta ULC, Department of Process Chemistry, 1021 Hayter Road NW, Edmonton, Alberta T6S 1A1, Canada
| | - Keshab Sarma
- Gilead Sciences Inc., Department of Process Chemistry, 333 Lakeside Drive, Foster City, California 94404, United States
| | - Elan Shao
- Gilead Alberta ULC, Department of Process Chemistry, 1021 Hayter Road NW, Edmonton, Alberta T6S 1A1, Canada
| | - Jinyu Shen
- Gilead Alberta ULC, Department of Process Chemistry, 1021 Hayter Road NW, Edmonton, Alberta T6S 1A1, Canada
| | - Mark V. Smith
- Gilead Alberta ULC, Department of Process Chemistry, 1021 Hayter Road NW, Edmonton, Alberta T6S 1A1, Canada
| | - Keiko Sujino
- Gilead Alberta ULC, Department of Process Chemistry, 1021 Hayter Road NW, Edmonton, Alberta T6S 1A1, Canada
| | - Alan S. Triman
- Gilead Sciences Inc., Department of Process Chemistry, 333 Lakeside Drive, Foster City, California 94404, United States
| | - Nande Wright
- Gilead Alberta ULC, Department of Process Chemistry, 1021 Hayter Road NW, Edmonton, Alberta T6S 1A1, Canada
| |
Collapse
|
13
|
Paul K, Hartmann T, Posch C, Behrens D, Herwig C. Investigation of cell line specific responses to pH inhomogeneity and consequences for process design. Eng Life Sci 2020; 20:412-421. [PMID: 32944016 PMCID: PMC7481767 DOI: 10.1002/elsc.202000034] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2020] [Revised: 06/15/2020] [Accepted: 06/25/2020] [Indexed: 12/13/2022] Open
Abstract
With increasing bioreactor volumes, the mixing time of the reactor increases as well, which creates an inhomogeneous environment for the cells. This can result in impaired process performance in large-scale production reactors. Particularly the addition of base through the reactor headspace can be problematic, since it creates an area, where cells are repeatedly exposed to an increased pH. The aim of this study is to simulate this large-scale phenomenon at lab-scale and investigate its impact. Two different cell lines were exposed to pH amplitudes of a maximal magnitude of 0.05 units (pH of 6.95). Both cell lines showed similar responses, like decreased viable cell counts, but unaffected lactate levels. However, cell line B showed an initially increased specific productivity in response to the introduced amplitudes, whereas cell line A showed a consistently lower specific productivity. Furthermore, the time point at which base addition is started influences the impact, which pH amplitudes have on process performance. When pH control was started earlier in the process, maximal viable cell counts decreased and the lactate metabolic shift was less pronounced. These results show that the potential negative impact of pH amplitudes can be minimized by strategic process design.
Collapse
Affiliation(s)
- Katrin Paul
- Institute of ChemicalEnvironmental and Bioscience EngineeringTU WienViennaAustria
- Christian Doppler Laboratory for Mechanistic and Physiological Methods for Improved BioprocessesTU WienViennaAustria
| | - Thomas Hartmann
- Institute of ChemicalEnvironmental and Bioscience EngineeringTU WienViennaAustria
- Christian Doppler Laboratory for Mechanistic and Physiological Methods for Improved BioprocessesTU WienViennaAustria
| | | | | | - Christoph Herwig
- Institute of ChemicalEnvironmental and Bioscience EngineeringTU WienViennaAustria
- Christian Doppler Laboratory for Mechanistic and Physiological Methods for Improved BioprocessesTU WienViennaAustria
| |
Collapse
|
14
|
Tsai AC, Jeske R, Chen X, Yuan X, Li Y. Influence of Microenvironment on Mesenchymal Stem Cell Therapeutic Potency: From Planar Culture to Microcarriers. Front Bioeng Biotechnol 2020; 8:640. [PMID: 32671039 PMCID: PMC7327111 DOI: 10.3389/fbioe.2020.00640] [Citation(s) in RCA: 37] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2020] [Accepted: 05/26/2020] [Indexed: 12/15/2022] Open
Abstract
Human mesenchymal stem cells (hMSCs) are a promising candidate in cell therapy as they exhibit multilineage differentiation, homing to the site of injury, and secretion of trophic factors that facilitate tissue healing and/or modulate immune response. As a result, hMSC-derived products have attracted growing interests in preclinical and clinical studies. The development of hMSC culture platforms for large-scale biomanufacturing is necessary to meet the requirements for late-phase clinical trials and future commercialization. Microcarriers in stirred-tank bioreactors have been widely utilized in large-scale expansion of hMSCs for translational applications because of a high surface-to-volume ratio compared to conventional 2D planar culture. However, recent studies have demonstrated that microcarrier-expanded hMSCs differ from dish- or flask-expanded cells in size, morphology, proliferation, viability, surface markers, gene expression, differentiation potential, and secretome profile which may lead to altered therapeutic potency. Therefore, understanding the bioprocessing parameters that influence hMSC therapeutic efficacy is essential for the optimization of microcarrier-based bioreactor system to maximize hMSC quantity without sacrificing quality. In this review, biomanufacturing parameters encountered in planar culture and microcarrier-based bioreactor culture of hMSCs are compared and discussed with specific focus on cell-adhesion surface (e.g., discontinuous surface, underlying curvature, microcarrier stiffness, porosity, surface roughness, coating, and charge) and the dynamic microenvironment in bioreactor culture (e.g., oxygen and nutrients, shear stress, particle collision, and aggregation). The influence of dynamic culture in bioreactors on hMSC properties is also reviewed in order to establish connection between bioprocessing and stem cell function. This review addresses fundamental principles and concepts for future design of biomanufacturing systems for hMSC-based therapy.
Collapse
Affiliation(s)
- Ang-Chen Tsai
- Department of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Florida State University, Tallahassee, FL, United States
| | - Richard Jeske
- Department of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Florida State University, Tallahassee, FL, United States
| | - Xingchi Chen
- Department of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Florida State University, Tallahassee, FL, United States
| | - Xuegang Yuan
- Department of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Florida State University, Tallahassee, FL, United States
| | - Yan Li
- Department of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Florida State University, Tallahassee, FL, United States
| |
Collapse
|
15
|
Xu S, Borys M, Khetan A, Pla I. Osmolality as a lever to modulate the N-glycolylneuraminicacid (Neu5Gc) level of a recombinant glycoprotein produced in Chinese hamster ovary cells. Biotechnol Prog 2020; 36:e3038. [PMID: 32542945 DOI: 10.1002/btpr.3038] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2020] [Revised: 06/11/2020] [Accepted: 06/12/2020] [Indexed: 12/19/2022]
Abstract
Glycoproteins could be highly sialylated, and controlling the sialic acid levels for some therapeutic proteins is critical to ensure product consistency and efficacy. N-acetylneuraminic acid (Neu5Ac, or NANA) and N-glycolylneuraminic acid (Neu5Gc, or NGNA) are the two most common forms of sialic acids produced in mammalian cells. As Neu5Gc is not produced in humans and can elicit immune responses, minimizing Neu5Gc formation is important in controlling this quality attribute for complex glycoproteins. In this study, a sialylated glycoprotein was used as the model molecule to study the effect of culture osmolality on Neu5Gc. A 14-day fed-batch process with osmolality maintained at physiological levels produced high levels of Neu5Gc. Increase of culture osmolality reduced the Neu5Gc level up to 70-80%, and the effect was proportional to the osmolality level. Through evaluating different osmolality conditions (300-450 mOsm/kg) under low or high pCO2 , we demonstrated that osmolality could be an effective process lever to modulate the Neu5Gc level. Potential mechanism of osmolality impact on Neu5Gc is discussed and is hypothesized to be cytosol NADH availability related. Compared with cell line engineering efforts, this simple process lever provides the opportunity to readily modulate the Neu5Gc level in a cell culture environment.
Collapse
Affiliation(s)
- Sen Xu
- Biologics Development, Bristol Myers Squibb Co, New Brunswick, New Jersey, USA
| | - Michael Borys
- Biologics Development, Bristol Myers Squibb Co., Devens, Massachusetts, USA
| | - Anurag Khetan
- Biologics Development, Bristol Myers Squibb Co, New Brunswick, New Jersey, USA
| | - Itzcoatl Pla
- Manufacturing Science and Technology, Bristol Myers Squibb Co, Devens, Massachusetts, USA
| |
Collapse
|
16
|
Zhang X, Jiang R, Lin H, Xu S. Feeding tricarboxylic acid cycle intermediates improves lactate consumption and antibody production in Chinese hamster ovary cell cultures. Biotechnol Prog 2020; 36:e2975. [PMID: 32012447 DOI: 10.1002/btpr.2975] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2019] [Revised: 12/11/2019] [Accepted: 01/26/2020] [Indexed: 12/12/2022]
Abstract
Media components play an important role in modulating cell metabolism and improving product titer in mammalian cell cultures. To sustain cell productivity, highly active oxidative metabolism is desired. Here we explored the effect of tricarboxylic acid (TCA) cycle intermediates supplementation on lactate metabolism and productivity in Chinese hamster ovary fed-batch cultures. Direct addition of 5 mM alpha-ketoglutarate (α-KG), malic acid, or succinic acid in the basal medium did not have any significant impact on culture performance. On the other hand, feeding α-KG, malic acid, and succinic acid in the stationary phase, either as a single solution or as a mixture, significantly improved lactate consumption, reduced ammonium accumulation, and led to higher cell specific productivity and antibody titer (~35% increase for the best condition). Delivering those intermediates as an acidic solution for pH control eliminated CO2 sparging and accumulation. Feeding TCA cycle intermediates was also demonstrated to be superior to feeding lactic acid or pyruvic acid in titer improvement. Taken together, feeding TCA cycle intermediates was effective in improving lactate consumption and increasing product titer, which is likely due to enhanced oxidative metabolism in an extended duration.
Collapse
Affiliation(s)
- Xiaolin Zhang
- Biologics Process Research & Development, Process Research & Development, Merck & Co., Inc., Kenilworth, New Jersey
| | - Rubin Jiang
- Biologics Process Research & Development, Process Research & Development, Merck & Co., Inc., Kenilworth, New Jersey
| | - Henry Lin
- Biologics Process Research & Development, Process Research & Development, Merck & Co., Inc., Kenilworth, New Jersey
| | - Sen Xu
- Biologics Process Research & Development, Process Research & Development, Merck & Co., Inc., Kenilworth, New Jersey.,Biologics Development, Bristol-Myers Squibb Co., Pennington 08534, NJ
| |
Collapse
|
17
|
Zhang X, Moroney J, Hoshan L, Jiang R, Xu S. Systematic evaluation of high-throughput scale-down models for single-use bioreactors (SUB) using volumetric gas flow rate as the criterion. Biochem Eng J 2019. [DOI: 10.1016/j.bej.2019.107307] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
18
|
Narayanan H, Luna MF, Stosch M, Cruz Bournazou MN, Polotti G, Morbidelli M, Butté A, Sokolov M. Bioprocessing in the Digital Age: The Role of Process Models. Biotechnol J 2019; 15:e1900172. [DOI: 10.1002/biot.201900172] [Citation(s) in RCA: 90] [Impact Index Per Article: 18.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2019] [Revised: 07/15/2019] [Indexed: 12/20/2022]
Affiliation(s)
- Harini Narayanan
- Institute for Chemical and Bioengineering ETHZ Zurich Switzerland
| | - Martin F. Luna
- Institute for Chemical and Bioengineering ETHZ Zurich Switzerland
| | | | - Mariano Nicolas Cruz Bournazou
- Institute for Chemical and Bioengineering ETHZ Zurich Switzerland
- DataHow AGc/o ETH ZurichHCI, F137Vladimir‐Prelog‐Weg 1 8093 Zurich Switzerland
| | - Gianmarco Polotti
- DataHow AGc/o ETH ZurichHCI, F137Vladimir‐Prelog‐Weg 1 8093 Zurich Switzerland
| | - Massimo Morbidelli
- Institute for Chemical and Bioengineering ETHZ Zurich Switzerland
- DataHow AGc/o ETH ZurichHCI, F137Vladimir‐Prelog‐Weg 1 8093 Zurich Switzerland
| | - Alessandro Butté
- Institute for Chemical and Bioengineering ETHZ Zurich Switzerland
- DataHow AGc/o ETH ZurichHCI, F137Vladimir‐Prelog‐Weg 1 8093 Zurich Switzerland
| | - Michael Sokolov
- Institute for Chemical and Bioengineering ETHZ Zurich Switzerland
- DataHow AGc/o ETH ZurichHCI, F137Vladimir‐Prelog‐Weg 1 8093 Zurich Switzerland
| |
Collapse
|